US calls on radiotherapy firms to join forces in improving safety
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has written to the manufacturers of radiotherapy devices, warning them of the need to take better account of the factors involved in “faulty design and user errors”, after receiving almost 1,200 such reports during the last decade1.